Highlights Xiangxue Pharmaceutical Co.,Ltd.

Equities

300147

CNE100000Y92

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 06/06/2024 BST			5-day change	1st Jan Change
3.28 ^CNY	+2.50%		-9.39%	-36.31%

04-29	Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-24	Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-24	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23	CI
Ji Qingsong agreed to acquire 18.87% stake in Hubei Tianji Pharmaceutical Co., Ltd. from Xiangxue Pharmaceutical Co.,Ltd. for CNY 200 million.	01/08/23	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	21/04/23	CI
Xiangxue Pharma Trims Losses in 2022	24/01/23	MT
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22	CI
Wuhan Yiyi Tongguan Enterprise Management Partnership (Limited Partnership) and Hubei Qingsong Yueyue Pharmaceutical Co., Ltd. agreed to acquire 35% stake in Hubei Tianji Pharmaceutical Co., Ltd. from Xiangxue Pharmaceutical Co.,Ltd. for CNY 385 million.	30/06/22	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22/04/22	CI
Xiangxue Pharmaceutical Unlocks 3.4 Million Restricted Shares; Shares Rally 13%	04/01/22	MT
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	26/10/21	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	27/08/21	CI
Guangdong Hengshu No. 1 Investment Partnership Enterprise (Limited Partnership) cancelled the acquisition of a 9.98% stake in Xiangxue Pharmaceutical Co.,Ltd. from Guangzhou Kunlun Investment Co., Ltd.	22/07/21	CI
Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	28/04/21	CI
Xiangxue Pharmaceutical Co.,Ltd. signed the share transfer agreement to acquire Guangzhou Xiehe Precision Medical Co., Ltd. from Guangzhou Kunlun Investment Co., Ltd. for CNY 1.5 billion.	26/03/21	CI
Guangdong Hengshu No. 1 Investment Partnership Enterprise (Limited Partnership) signed an agreement to acquire a 9.98% stake in Xiangxue Pharmaceutical Co.,Ltd. from Guangzhou Kunlun Investment Co., Ltd. for approximately CNY 390 million.	09/03/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Xiangxue Pharmaceutical Co.,Ltd.

Equities

300147

CNE100000Y92

Highlights

Filters